Amit M. Oza, MD
Amit M. Oza, MD
Department of Medicine
Princess Margaret Hospital
190 Elizabeth Street
Toronto,
ON
Canada
M5G 2C4
Papers:
2 - Seminal Abstract
ICON 7: Final overall survival results in teh GCIG phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer
4 - Seminal Abstract
A phase III, randomized, double-blind trialof weekly paclitaxel plus the angiopoientin 1 and 2 inhibitor, trebananib, or placebo in women with recurrent ovarian cancer: TRINOVA-1
101 -Featured Poster
Evaluation of CA-125 response in the TRINOVA-1 study of weekly paclitaxel plus trebananib or placebo in women with recurrent ovarian cancer